Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5074089013 | Acetaminophen 325 mg and chlorzoxazone 500 mg and diclofenac sodium 50 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5074090016 | Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5074091017 | Product containing precisely chlorzoxazone 500 milligram and diclofenac sodium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Is a | Chlorzoxazone and diclofenac and paracetamol only product in oral dose form | true | Inferred relationship | Some | ||
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has precise active ingredient | Paracetamol | true | Inferred relationship | Some | 1 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has basis of strength substance (attribute) | Paracetamol | true | Inferred relationship | Some | 1 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has precise active ingredient | Chlorzoxazone | true | Inferred relationship | Some | 2 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has basis of strength substance (attribute) | Chlorzoxazone | true | Inferred relationship | Some | 2 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has precise active ingredient | Diclofenac sodium | true | Inferred relationship | Some | 3 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has basis of strength substance (attribute) | Diclofenac sodium | true | Inferred relationship | Some | 3 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets